Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/16:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(16:0/16:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/15:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)) (HMDB: HMDB0000250)
- Ammonia Recycling (HMDB: HMDB0000250)
- Biotin Metabolism (HMDB: HMDB0000250)
- Alanine Metabolism (HMDB: HMDB0000250)
- Aspartate Metabolism (HMDB: HMDB0000250)
- Glutamate Metabolism (HMDB: HMDB0000250)
- Selenoamino Acid Metabolism (HMDB: HMDB0000250)
- Amino Sugar Metabolism (HMDB: HMDB0000250)
- Arginine and Proline Metabolism (HMDB: HMDB0000250)
- Betaine Metabolism (HMDB: HMDB0000250)
- Butyrate Metabolism (HMDB: HMDB0000250)
- Cysteine Metabolism (HMDB: HMDB0000250)
- Ethanol Degradation (HMDB: HMDB0000250)
- Fatty Acid Metabolism (HMDB: HMDB0000250)
- Fructose and Mannose Degradation (HMDB: HMDB0000250)
- Nucleotide Sugars Metabolism (HMDB: HMDB0000250)
- Pantothenate and CoA Biosynthesis (HMDB: HMDB0000250)
- Phenylacetate Metabolism (HMDB: HMDB0000250)
- Riboflavin Metabolism (HMDB: HMDB0000250)
- Spermidine and Spermine Biosynthesis (HMDB: HMDB0000250)
- Ubiquinone Biosynthesis (HMDB: HMDB0000250)
- Sulfate/Sulfite Metabolism (HMDB: HMDB0000250)
- Phytanic Acid Peroxisomal Oxidation (HMDB: HMDB0000250)
- Phenylalanine and Tyrosine Metabolism (HMDB: HMDB0000250)
- Histidine Metabolism (HMDB: HMDB0000250)
- Lactose Synthesis (HMDB: HMDB0000250)
- Steroid Biosynthesis (HMDB: HMDB0000250)
- Purine Metabolism (HMDB: HMDB0000250)
- Pyruvate Metabolism (HMDB: HMDB0000250)
- Methionine Metabolism (HMDB: HMDB0000250)
- Inositol Metabolism (HMDB: HMDB0000250)
- Bile Acid Biosynthesis (HMDB: HMDB0000250)
- Propanoate Metabolism (HMDB: HMDB0000250)
- Starch and Sucrose Metabolism (HMDB: HMDB0000250)
- Nicotinate and Nicotinamide Metabolism (HMDB: HMDB0000250)
- Oxidation of Branched-Chain Fatty Acids (HMDB: HMDB0000250)
- Glycine and Serine Metabolism (HMDB: HMDB0000250)
- Galactose Metabolism (HMDB: HMDB0000250)
- Pyrimidine Metabolism (HMDB: HMDB0000250)
- Urea Cycle (HMDB: HMDB0000250)
- Tryptophan Metabolism (HMDB: HMDB0000250)
- Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids (HMDB: HMDB0000250)
- Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids (HMDB: HMDB0000250)
- Mercaptopurine Metabolism Pathway (HMDB: HMDB0000250)
- Valproic Acid Metabolism Pathway (HMDB: HMDB0000250)
- Thioguanine Metabolism Pathway (HMDB: HMDB0000250)
- Lamivudine Metabolism Pathway (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/14:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/20:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/14:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/18:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/22:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(16:0/14:0) (HMDB: HMDB0000250)
- Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/14:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/14:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/15:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/18:1(11Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/18:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/20:4(8Z,11Z,14Z,17Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/22:1(13Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/22:2(13Z,16Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:0/24:1(15Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/14:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:1(9Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:3(6Z,9Z,12Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/18:3(9Z,12Z,15Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:3(8Z,11Z,14Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/24:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/14:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/15:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/16:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/18:0) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/18:1(11Z)) (HMDB: HMDB0000250)
- Phosphatidylethanolamine Biosynthesis PE(15:0/18:1(9Z)) (HMDB: HMDB0000250)
- Cardiolipin Biosynthesis CL(18:0/18:0/18:0/18:0) (HMDB: HMDB0000250)
Disease pathway- Methylenetetrahydrofolate Reductase Deficiency (MTHFRD) (HMDB: HMDB0000250)
- Sialuria or French Type Sialuria (HMDB: HMDB0000250)
- Dimethylglycine Dehydrogenase Deficiency (HMDB: HMDB0000250)
- Multiple Carboxylase Deficiency, Neonatal or Early Onset Form (HMDB: HMDB0000250)
- Myoadenylate Deaminase Deficiency (HMDB: HMDB0000250)
- Fructosuria (HMDB: HMDB0000250)
- Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency (HMDB: HMDB0000250)
- Trifunctional Protein Deficiency (HMDB: HMDB0000250)
- Cystinosis, Ocular Nonnephropathic (HMDB: HMDB0000250)
- Citrullinemia Type I (HMDB: HMDB0000250)
- Hyperinsulinism-Hyperammonemia Syndrome (HMDB: HMDB0000250)
- Tay-Sachs Disease (HMDB: HMDB0000250)
- Molybdenum Cofactor Deficiency (HMDB: HMDB0000250)
- Cerebrotendinous Xanthomatosis (CTX) (HMDB: HMDB0000250)
- Glycogen Synthetase Deficiency (HMDB: HMDB0000250)
- Dihydropyrimidinase Deficiency (HMDB: HMDB0000250)
- Methylmalonic Aciduria Due to Cobalamin-Related Disorders (HMDB: HMDB0000250)
- Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency) (HMDB: HMDB0000250)
- Hypercholesterolemia (HMDB: HMDB0000250)
- Glutaric Aciduria Type I (HMDB: HMDB0000250)
- Mevalonic Aciduria (HMDB: HMDB0000250)
- Prolidase Deficiency (PD) (HMDB: HMDB0000250)
- Pyruvate Carboxylase Deficiency (HMDB: HMDB0000250)
- Pyruvate Dehydrogenase Complex Deficiency (HMDB: HMDB0000250)
- Beta-Mercaptolactate-Cysteine Disulfiduria (HMDB: HMDB0000250)
- Cholesteryl Ester Storage Disease (HMDB: HMDB0000250)
- Hyperprolinemia Type II (HMDB: HMDB0000250)
- Carnitine Palmitoyl Transferase Deficiency II (HMDB: HMDB0000250)
- Leigh Syndrome (HMDB: HMDB0000250)
- Carbamoyl Phosphate Synthetase Deficiency (HMDB: HMDB0000250)
- 3-Phosphoglycerate Dehydrogenase Deficiency (HMDB: HMDB0000250)
- Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) (HMDB: HMDB0000250)
- Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) (HMDB: HMDB0000250)
- UMP Synthase Deficiency (Orotic Aciduria) (HMDB: HMDB0000250)
- Succinic Semialdehyde Dehydrogenase Deficiency (HMDB: HMDB0000250)
- Ornithine Aminotransferase Deficiency (OAT Deficiency) (HMDB: HMDB0000250)
- Refsum Disease (HMDB: HMDB0000250)
- Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome] (HMDB: HMDB0000250)
- Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD) (HMDB: HMDB0000250)
- Wolman Disease (HMDB: HMDB0000250)
- Methionine Adenosyltransferase Deficiency (HMDB: HMDB0000250)
- Mucopolysaccharidosis VI. Sly Syndrome (HMDB: HMDB0000250)
- Canavan Disease (HMDB: HMDB0000250)
- Hyperglycinemia, Non-Ketotic (HMDB: HMDB0000250)
- Malonic Aciduria (HMDB: HMDB0000250)
- Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type (HMDB: HMDB0000250)
- Non-Ketotic Hyperglycinemia (HMDB: HMDB0000250)
- Familial Hypercholanemia (FHCA) (HMDB: HMDB0000250)
- Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) (HMDB: HMDB0000250)
- Pyruvate Kinase Deficiency (HMDB: HMDB0000250)
- CHILD Syndrome (HMDB: HMDB0000250)
- Smith-Lemli-Opitz Syndrome (SLOS) (HMDB: HMDB0000250)
- Hyperornithinemia with Gyrate Atrophy (HOGA) (HMDB: HMDB0000250)
- Argininemia (HMDB: HMDB0000250)
- Dihydropyrimidine Dehydrogenase Deficiency (DHPD) (HMDB: HMDB0000250)
- Galactosemia III (HMDB: HMDB0000250)
- Biotinidase Deficiency (HMDB: HMDB0000250)
- 27-Hydroxylase Deficiency (HMDB: HMDB0000250)
- Congenital Bile Acid Synthesis Defect Type III (HMDB: HMDB0000250)
- Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) (HMDB: HMDB0000250)
- Primary Hyperoxaluria Type I (HMDB: HMDB0000250)
- Histidinemia (HMDB: HMDB0000250)
- Xanthine Dehydrogenase Deficiency (Xanthinuria) (HMDB: HMDB0000250)
- Galactosemia II (GALK) (HMDB: HMDB0000250)
- Lesch-Nyhan Syndrome (LNS) (HMDB: HMDB0000250)
- L-Arginine:Glycine Amidinotransferase Deficiency (HMDB: HMDB0000250)
- 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency (HMDB: HMDB0000250)
- Sulfite Oxidase Deficiency (HMDB: HMDB0000250)
- Adenine Phosphoribosyltransferase Deficiency (APRT) (HMDB: HMDB0000250)
- Desmosterolosis (HMDB: HMDB0000250)
- AICA-Ribosiduria (HMDB: HMDB0000250)
- MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy) (HMDB: HMDB0000250)
- Tyrosinemia Type 3 (TYRO3) (HMDB: HMDB0000250)
- Ornithine Transcarbamylase Deficiency (OTC Deficiency) (HMDB: HMDB0000250)
- Phenylketonuria (HMDB: HMDB0000250)
- G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease (HMDB: HMDB0000250)
- Hyper-IgD Syndrome (HMDB: HMDB0000250)
- Lysosomal Acid Lipase Deficiency (Wolman Disease) (HMDB: HMDB0000250)
- Adenosine Deaminase Deficiency (HMDB: HMDB0000250)
- Ethylmalonic Encephalopathy (HMDB: HMDB0000250)
- Zellweger Syndrome (HMDB: HMDB0000250)
- Sarcosine Oncometabolite Pathway (HMDB: HMDB0000250)
- Xanthinuria Type I (HMDB: HMDB0000250)
- Lactic Acidemia (HMDB: HMDB0000250)
- Tyrosinemia Type 2 (or Richner-Hanhart Syndrome) (HMDB: HMDB0000250)
- Galactosemia (HMDB: HMDB0000250)
- Prolinemia Type II (HMDB: HMDB0000250)
- Glycogenosis, Type IV. Amylopectinosis, Anderson Disease (HMDB: HMDB0000250)
- Fructose Intolerance, Hereditary (HMDB: HMDB0000250)
- Sarcosinemia (HMDB: HMDB0000250)
- Malonyl-CoA Decarboxylase Deficiency (HMDB: HMDB0000250)
- Mitochondrial DNA Depletion Syndrome (HMDB: HMDB0000250)
- Glycogenosis, Type VI. Hers Disease (HMDB: HMDB0000250)
- Beta-Ureidopropionase Deficiency (HMDB: HMDB0000250)
- Glycine N-Methyltransferase Deficiency (HMDB: HMDB0000250)
- Cystathionine beta-Synthase Deficiency (HMDB: HMDB0000250)
- Sucrase-Isomaltase Deficiency (HMDB: HMDB0000250)
- Homocarnosinosis (HMDB: HMDB0000250)
- Congenital Disorder of Glycosylation CDG-IId (HMDB: HMDB0000250)
- Hypoacetylaspartia (HMDB: HMDB0000250)
- Gout or Kelley-Seegmiller Syndrome (HMDB: HMDB0000250)
- Salla Disease/Infantile Sialic Acid Storage Disease (HMDB: HMDB0000250)
- Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) (HMDB: HMDB0000250)
- GLUT-1 Deficiency Syndrome (HMDB: HMDB0000250)
- Congenital Bile Acid Synthesis Defect Type II (HMDB: HMDB0000250)
- Hypermethioninemia (HMDB: HMDB0000250)
- Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD) (HMDB: HMDB0000250)
- 2-Hydroxyglutric Aciduria (D and L Form) (HMDB: HMDB0000250)
- Argininosuccinic Aciduria (HMDB: HMDB0000250)
- Xanthinuria Type II (HMDB: HMDB0000250)
- Primary Hyperoxaluria II, PH2 (HMDB: HMDB0000250)
- S-Adenosylhomocysteine (SAH) Hydrolase Deficiency (HMDB: HMDB0000250)
- Hyperprolinemia Type I (HMDB: HMDB0000250)
- Adenylosuccinate Lyase Deficiency (HMDB: HMDB0000250)
- Purine Nucleoside Phosphorylase Deficiency (HMDB: HMDB0000250)
- Carnitine Palmitoyl Transferase Deficiency I (HMDB: HMDB0000250)
- Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis (HMDB: HMDB0000250)
Drug action pathwaySignaling pathwayProtein pathway |
---|